MD Revolution Acquires NavCare to Expand Remote Patient Care Management Services

"MD Revolution offers not only extensive experience but also the best technology platform, and proven SaaS offering, to serve our growing client base" said Rick Griffin, CEO, NavCare. "We share the same culture and desire to provide exceptional personalized care to our patients, along with maintaining the highest clinical standards."

MD Revolution, a leading provider of remote care management and clinical services has acquired NavCare, a remote patient care services company specializing in comprehensive chronic care management (CCM).

The acquisition provides NavCare clients with enhanced clinical and patient management tools, patient engagement applications and bi-directional integrations. Direct patient care will continue to be delivered by the same teams as NavCare patients migrate to MD Revolution’s RevUp Care Management Platform. The expanded leadership team will support all clients.

MD Revolution has been at the forefront of remote health innovation since 2011, providing remote patient monitoring (RPM) and CCM to over 1,700 providers and 150,000 patients, collecting and evaluating over 19 million vital measurements through care delivery.

NavCare has been providing proactive and preventative health assessments, screenings, and vital tracking through connected remote monitoring devices, 24/7 Care Team support, and the NavCare Connect integrated health platform since 2008. NavCare is located in Augusta, Georgia.

“MD Revolution offers not only extensive experience but also the best technology platform, and proven SaaS offering, to serve our growing client base” said Rick Griffin, CEO, NavCare. “We share the same culture and desire to provide exceptional personalized care to our patients, along with maintaining the highest clinical standards.”

NavCare teams will become employees of MD Revolution. Chris MacInnis will become Chief Operating Officer of MD Revolution and Theresa Lantz will become Vice President of Client Success. They will Join Kyle Williams, CEO, Paul Huffman, VP of Sales and Marketing and Michael Moore, VP of Product Management to lead the combined teams.

“NavCare’s experience in hospitals and its track record with annual wellness visits (AWV) and transitional care management (TCM) aligns with our growth strategy,” said Kyle Williams, CEO, MD Revolution. “Our operations will allow for better scaling of services and our combined care delivery and account management teams will mean improved capabilities benefitting all of our clients.”

Williams said that this merger will lead to MD Revolution being able to offer greatly expanded service to clients and patients.

“With this new relationship, we look forward to continued growth as we expand our services to the marketplace,” Williams said.

More

Artificial Intelligence Tools Make Education Materials More Patient Friendly

April 30, 2025

“Our study shows that widely used large language models have the potential to transform patient education materials into more readable content, which is essential for patient empowerment and better health outcomes,” said Study senior author Jonah Feldman, MD, medical director of transformation and informatics at NYU Langone.

CorWave Completes 6-Month In Vivo Study for Clinical Trials Initiation

April 24, 2025

In vivo studies demonstrated the pump’s successful operation for a period of up to six months. Additionally, nine chronic ovine implants were conducted for 60 days with no device failure or sign of thrombosis at explant. These significant milestones mark the final stage of CorWave’s preclinical development, paving the way for its First-In-Human study.